SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026182
Filing Date
2023-09-18
Accepted
2023-09-18 16:01:54
Documents
14
Period of Report
2023-09-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tmbr20230914_8k.htm   iXBRL 8-K 37840
2 EXHIBIT 99.1 PRESS RELEASE ex_569723.htm EX-99.1 11248
  Complete submission text file 0001437749-23-026182.txt   187625

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20230912.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20230912_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20230912_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20230912_pre.xml EX-101.PRE 11584
8 EXTRACTED XBRL INSTANCE DOCUMENT tmbr20230914_8k_htm.xml XML 2562
Mailing Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059
Business Address 3 MOUNTAINVIEW ROAD, SUITE 100 WARREN NJ 07059 (917) 697-3130
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 231261157
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences